Dr. Roupen Odabashian, MD
Author profile

Dr. Roupen Odabashian, MD

Medical Oncologist, Abbotsford Regional Hospital

MD, FRCPC · Medical Oncologist, Abbotsford Regional Hospital · Hematology-Oncology Fellowship, Karmanos Cancer Institute / Wayne State University · ABIM Internal Medicine & Medical Oncology · RCPSC Medical Oncology & Internal Medicine

Dr. Roupen Odabashian is a medical oncologist at Abbotsford Regional Hospital in British Columbia, Canada. He completed his hematology-oncology fellowship at the Karmanos Cancer Institute / Wayne State University School of Medicine in Detroit, Michigan (2023–2026).

He completed his Internal Medicine residency at The Ottawa Hospital / University of Ottawa in Canada (2019–2023), where he received the PARO Resident Teaching Award (2023) for outstanding clinical teaching of junior house-staff and clinical clerks. He earned his Doctor of Medicine degree cum laude from the University of Aleppo Faculty of Medicine in Syria.

Board Certifications

  • American Board of Internal Medicine — Medical Oncology (2025)
  • American Board of Internal Medicine — Internal Medicine (2022)
  • Royal College of Physicians and Surgeons of Canada — Medical Oncology (2025)
  • Royal College of Physicians and Surgeons of Canada — Internal Medicine (2022)

Research and Clinical Interests

  • Thoracic oncology, with a focus on BRAF-mutated non-small cell lung cancer
  • Artificial intelligence applications in oncology and clinical decision support
  • Large language model benchmarking against expert oncology reasoning
  • Genitourinary oncology supportive care and toxicity management

Selected Publications

Dr. Odabashian's peer-reviewed work has appeared in JMIR AI, Cancer Research, Statistics and Treatment, Cancers, Heart Rhythm, CJC Open, International Journal of Molecular Sciences, Expert Opinion on Biological Therapy, and Thrombosis Research, with abstracts under review at ASCO 2026. Highlights:

  • Targeting two pathways at once: the emerging role of bispecific antibodies in NSCLC and SCLC — Odabashian R, Mamdani H. (2026)
  • Benchmarking clinical reasoning and accuracy of large language models on breast oncology multiple-choice questions — Odabashian R, et al. (2026)
  • Evaluating artificial intelligence as a clinical decision support tool for lung cancer treatment recommendations — Odabashian R, et al. (2025)
  • Assessment of ChatGPT-3.5's Knowledge in Oncology: Comparative Study with ASCO-SEP Benchmarks — Odabashian R, et al. JMIR AI (2024)
  • Diagnosis and Management of Skin Toxicities in Systemic Treatment of Genitourinary Cancers — Chowdhury D, ..., Odabashian R, et al. Cancers (2024)

Editorial and Peer Review

  • Peer reviewer, Canadian Medical Association Journal (CMAJ) — AI in healthcare (2024–present)
  • Peer reviewer, Journal of Medical Artificial Intelligence (JMAI) — AI in healthcare (2023–present)

Healthcare Innovation

  • Founder, MeDucation AI (2025–present) — AI-powered medical education platform for medical students, residents, and oncology fellows
  • Medical Advisor, HaloHealth Canada (2023–present) — bridging health technology and clinical practice
  • Collaborator, OncoDaily Podcast (2023–present) — co-hosting episodes on developments in oncology

Invited Lectures

  • University of Ottawa, Faculty of Medicine — annually invited (2023–2025) to lecture on entrepreneurship and innovation in healthcare and medicine

Full publication list

Browse the complete bibliography on ORCID and Doximity.